BRIEF—Lilly ups forecast for 2019

Eli Lilly has provided updated guidance, forecasting revenue and adjusted profit figures for 2019 that are higher than expected.

Shares in the US-based drugmaker ticked upwards, as it forecast adjusted profit of between $5.90 and $6 per share, above analysts’ expectations.

Lilly said it thought global revenue would come in at between $25.3 billion and $25.8 billion in 2019.